Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Biologics Awarded as "Most Honored Company" by Institutional Investor 2020-08-04 17:00
Embrace Change to Turn Challenges into Opportunities: WuXi Biologics Successfully Hosted the 2nd Investor Day 2020-06-19 17:56
WuXi Biologics (Suzhou) Received EMA GMP Certificate for Biosafety Testing 2020-06-16 08:00
WuXi Biologics Signs Lease for a Clinical Manufacturing Facility in the United States 2020-06-09 08:00
WuXi Biologics Sweeps 2020 CMO Leadership Awards in All Six Categories 2020-05-28 08:00
WuXi Biologics Closes Land Deal to Build State-of-the-Art Biologics Production Facility in the United States 2020-05-19 08:00
WuXi Biologics and Aravive Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies Targeting Cancer and Fibrosis Using the WuXiBody™ Platform 2020-04-30 19:00
WuXi Biologics Successfully Completes PFS Filling at its Robotic Aseptic Filling Facility 2020-04-28 08:00
WuXi Biologics Completed Acquisition of a Drug Product Manufacturing Facility in Germany 2020-04-22 08:00
WuXi Biologics (Suzhou) Successfully Passed First EMA GMP Inspection 2020-04-14 08:00
WuXi Biologics Achieved Remarkable Results in 2019 2020-03-26 21:32
WuXi Biologics Completes Weather-Tight Seal of its Biologics Manufacturing Facility in Ireland 2020-03-11 08:00
WuXi Biologics and Vir Biotechnology Announce Collaboration for Global Development of Antibodies to Treat COVID-19 2020-02-25 21:30
WuXi Biologics Congratulates Immutep on Positive Interim Data for IMP-321 2020-02-24 08:00
WuXi Biologics' Subsidiary WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader 2020-02-18 18:42
WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader 2020-02-18 18:18
WuXi Biologics Provides Back-to-work Operation Update Related to the Coronavirus Outbreak 2020-02-12 08:00
WuXi Biologics Provides Operation Update Related to the Coronavirus Outbreak 2020-01-29 10:44
WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus 2020-01-29 10:00
WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany 2020-01-16 10:39
1 3 4 5 6 7 9